New Drugs and Interventional Strategies for the Management of Hypertension

Curr Pharm Des. 2021;27(11):1396-1406. doi: 10.2174/1381612826666201106091527.

Abstract

Essential hypertension is an important cause of cardiovascular morbidity and mortality worldwide with significant clinical and economic implications. The field of antihypertensive treatment already numbers numerous agents and classes of drugs. However, patients are still developing uncontrolled hypertension. Hence there is a continuous need for novel agents with good tolerability. Advances in this field are focusing both on pharmacotherapy, with the developments in traditional and non-traditional targets, as well as interventional techniques such as renal denervation and baroreflex activation therapy. It is likely that future strategies may involve a tailored approach to the individual patient, with genetic modulation playing a key role.

Keywords: Hypertension; blood pressure; drug; intervention; novel; therapy.

MeSH terms

  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • Baroreflex
  • Blood Pressure
  • Humans
  • Hypertension* / drug therapy
  • Pharmaceutical Preparations*

Substances

  • Antihypertensive Agents
  • Pharmaceutical Preparations